Association between C282Y and H63D mutations of the HFE gene with hepatocellular carcinoma in European populations: a meta-analysis
- PMID: 20196837
- PMCID: PMC2845109
- DOI: 10.1186/1756-9966-29-18
Association between C282Y and H63D mutations of the HFE gene with hepatocellular carcinoma in European populations: a meta-analysis
Abstract
Background: Hereditary hemochromatosis (HH) is an autosomal recessive disorder mainly associated with homozygosity for the C282Y and H63D mutations in the hemochromatosis (HFE) gene. The reports about the C282Y and H63D mutations and hepatocellular carninoma (HCC) were controversial. To clarify the relationship between C282Y and H63D mutations and HCC, a meta-analysis including nine studies (1102 HCC cases and 3766 controls, mainly came from European populations) was performed.
Methods: The association was measured using random-effect (RE) or fixed-effect (FE) odds ratios (ORs) combined with 95% confidence intervals (CIs) according to the studies' heterogeneity.
Results: Meta-analysis of nine studies showed that Y allele of C282Y was associated with HCC risk: RE OR reached 1.50 (95%CI: 1.05-2.14, p for heterogeneity = 0.02, I2 = 0.57). Subgroup analysis of seven studies also showed Y allele was associated with HCC risk in healthy populations: RE OR reached 1.61 (95%CI: 1.08-2.39, p for heterogeneity = 0.04, I2 = 0.55). We further did subgroup analysis in alcoholic liver cirrhosis (LC) patients of four studies (224 cases and 380 controls) and found that both the dominant model and Y allele of C282Y were associated with HCC risk (FE OR reached 4.06, 95%CI: 2.08-7.92 and 3.41, 95%CI: 1.81-6.41, respectively). There was no distinct heterogeneity among the studies (I2 = 0). Sensitivity analyses showed the results were robust in the subgroup analysis of alcoholic LC patients.
Conclusions: C282Y mutation was associated with HCC in European alcoholic LC patients.
Figures




Similar articles
-
Risk of Hepatocellular Carcinoma in Patients with Various HFE Genotypes.Dig Dis Sci. 2023 Jan;68(1):312-322. doi: 10.1007/s10620-022-07602-9. Epub 2022 Jul 5. Dig Dis Sci. 2023. PMID: 35790703
-
Prevalence of common HFE and SERPINA1 mutations in patients with hepatocellular carcinoma in a Moroccan population.Arch Med Res. 2008 Feb;39(2):236-41. doi: 10.1016/j.arcmed.2007.09.006. Arch Med Res. 2008. PMID: 18164971
-
Mutations of the HFE gene in patients with hepatocellular carcinoma.Am J Gastroenterol. 2003 Feb;98(2):442-7. doi: 10.1111/j.1572-0241.2003.07222.x. Am J Gastroenterol. 2003. PMID: 12591066
-
Mutations in the HFE gene and sporadic amyotrophic lateral sclerosis risk: a meta-analysis of observational studies.Braz J Med Biol Res. 2014 Feb;47(3):215-22. doi: 10.1590/1414-431X20133296. Epub 2014 Feb 18. Braz J Med Biol Res. 2014. PMID: 24604426 Free PMC article. Review.
-
Contribution of different HFE genotypes to iron overload disease: a pooled analysis.Genet Med. 2000 Sep-Oct;2(5):271-7. doi: 10.1097/00125817-200009000-00001. Genet Med. 2000. PMID: 11399207 Review.
Cited by
-
Molecular Epidemiology of Hepatocellular Carcinoma.Clin Liver Dis (Hoboken). 2012 Dec 1;1(6):177-179. doi: 10.1002/cld.117. Clin Liver Dis (Hoboken). 2012. PMID: 26213618 Free PMC article. No abstract available.
-
Molecular pathological epidemiology in diabetes mellitus and risk of hepatocellular carcinoma.World J Hepatol. 2016 Sep 28;8(27):1119-1127. doi: 10.4254/wjh.v8.i27.1119. World J Hepatol. 2016. PMID: 27721917 Free PMC article. Review.
-
Association between the HFE C282Y, H63D Polymorphisms and the Risks of Non-Alcoholic Fatty Liver Disease, Liver Cirrhosis and Hepatocellular Carcinoma: An Updated Systematic Review and Meta-Analysis of 5,758 Cases and 14,741 Controls.PLoS One. 2016 Sep 22;11(9):e0163423. doi: 10.1371/journal.pone.0163423. eCollection 2016. PLoS One. 2016. PMID: 27657935 Free PMC article.
-
C282Y polymorphism in the HFE gene is associated with risk of breast cancer.Tumour Biol. 2013 Oct;34(5):2759-64. doi: 10.1007/s13277-013-0833-9. Epub 2013 May 17. Tumour Biol. 2013. PMID: 23681799
-
HFE genetic variability and risk of alcoholic liver disease: A meta-analysis.J Huazhong Univ Sci Technolog Med Sci. 2016 Oct;36(5):626-633. doi: 10.1007/s11596-016-1637-0. Epub 2016 Oct 18. J Huazhong Univ Sci Technolog Med Sci. 2016. PMID: 27752890
References
-
- Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, Camerini T, Roayaie S, Schwartz ME, Grazi GL, Adam R, Neuhaus P, Salizzoni M, Bruix J, Forner A, De Carlis L, Cillo U, Burroughs AK, Troisi R, Rossi M, Gerunda GE, Lerut J, Belghiti J, Boin I, Gugenheim J, Rochling F, Van Hoek B, Majno P. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol. 2009;10(1):35–43. doi: 10.1016/S1470-2045(08)70284-5. - DOI - PubMed
-
- Edwards CQ, Dadone MM, Skolnick MH, Kushner JP. Hereditary haemochromatosis. Clin Haematol. 1982;11(2):411–435. - PubMed
-
- Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med. 1985;313(20):1256–1262. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical